Past Week’s Most Important Stock News

Week of March 02, 2026

The S&P 500 Index, tracked by the Vanguard S&P 500 ETF (VOO), experienced a week of moderate volatility, ultimately closing down slightly as investors digested fresh economic data and corporate announcements. The primary market driver was the release of the February 2026 Consumer Price Index (CPI) mid-week, which showed inflation easing more slowly than anticipated, leading to renewed concerns about the Federal Reserve’s interest rate trajectory. While core inflation remained sticky, the headline figure’s persistent elevation dampened hopes for aggressive rate cuts in the near term, causing a dip in growth stocks and bond yields to tick higher. Federal Reserve Chair Powell’s subsequent remarks hinted at a patient approach to monetary policy, emphasizing data dependency, which slightly calmed fears but reinforced a “higher for longer” sentiment that pressured equity valuations, particularly in rate-sensitive sectors.

On the corporate earnings front, several bellwether companies within the S&P 500 reported their Q4 2025 results and Q1 2026 guidance. NVIDIA (NVDA) continued its stellar performance, reporting record revenues and an upbeat outlook driven by insatiable demand for its next-generation AI accelerators and data center solutions. The positive report provided a lift to the broader technology sector, particularly semiconductor and AI-related stocks, which are significant components of VOO. Conversely, Starbucks (SBUX) saw its stock decline after missing analyst expectations on same-store sales growth, particularly in key international markets, signaling potential headwinds in consumer discretionary spending and competitive pressures. These divergent performances underscored the market’s current selectivity, rewarding companies demonstrating strong secular growth drivers while penalizing those facing demand challenges.

Further impacting market sentiment were ongoing discussions surrounding regulatory scrutiny in the technology sector. Reports surfaced of the Department of Justice advancing investigations into alleged anti-competitive practices by a major cloud computing provider, leading to some selling pressure on large-cap tech companies, including those heavily weighted in the S&P 500. While specific actions remain uncertain, the renewed focus on antitrust could introduce a layer of uncertainty for these dominant players. Additionally, a significant strategic acquisition was announced with Johnson & Johnson (JNJ) confirming its intent to acquire a smaller, innovative biotech firm specializing in gene therapy for approximately $15 billion. This move highlights the continued consolidation and pursuit of high-growth therapeutic areas within the healthcare sector, a trend that could boost innovation and future earnings for the S&P 500’s pharmaceutical giants.

Looking ahead, the market’s focus remains squarely on inflation trends and the Federal Reserve’s response. The coming weeks will see further economic indicators and corporate updates that will likely shape investor expectations regarding monetary policy and corporate earnings power. For VOO investors, the key takeaways from the past week emphasize the importance of broad diversification amidst sector-specific movements and the overriding influence of macroeconomic factors, particularly interest rate expectations, on overall market direction.

Sources